Dr. Şahin and Dr. Türeci, who teamed up with Pfizer early in the COVID-19 pandemic to develop an mRNA-based vaccine, have been researching cancer treatments for 30 years. Dr. Şahin said cancer vaccines will be ready “before 2030.”
“We feel a cure for cancer or to changing cancer patients’ lives is in our grasp,” Dr. Türeci told the BBC. “As scientists, we are always hesitant to say, ‘We will have a cure for cancer.’ We have a number of breakthroughs and we will continue to work on them.”
This follows the rough timeline other researchers have pointed to as other drugmakers are ramping up efforts to develop a cancer vaccine. On Oct. 12, Moderna and Merck said they are partnering under a $250 million agreement to develop, manufacture and sell personalized cancer vaccine candidates.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
